Daniel Gil, PhD

Chief Executive Officer
Pelage Pharmaceuticals

Biography

Dr. Gil has had a 30+ year career in Pharmaceutical R&D. He is CEO of Pelage Pharmaceuticals, which is conducting clinical trials on a regenerative hair growth treatment. He is also a Venture Partner with Visionary Ventures, an ophthalmology and aesthetics-focused fund. Until 2018, Dr. Gil worked at Allergan. As VP, Research Technologies and Portfolio, he oversaw preclinical to early phase 2 clinical development and directed the Medicinal Chemistry, Biologics and translational pharmacology research groups. His research contributed to development of 5 marketed drugs and he led 8 clinical development projects in the areas of Ophthalmology, Neuroscience and Dermatology. He is an inventor on more than 70 issued US patents and author on 50 peer-reviewed research articles. Dr. Gil has an undergraduate degree in Biology from Harvard University and a PhD in Pharmacology from the University of Pennsylvania.